Table 4.
All participants | Human immunodeficiency virus (HIV) positive | HIV negative | ||
---|---|---|---|---|
log (Neopterin) | log (sTNFR-1) | 0.467 (0.054)** | 0.542 (0.104)** | 0.487 (0.061)** |
log (sTNFR-2) | 0.569 (0.039)** | 0.476 (0.073)** | 0.622 (0.044)** | |
log (IL-6) | −0.042 (0.018)* | −0.034 (0.042) | −0.040 (0.020)* | |
log(CRP) | −0.014 (0.011) | −0.030 (0.021) | −0.003 (0.013) |
**p < 0.0001, *p < 0.05.
All models adjusted for age, sex, race, number of comorbidities (0 or 1, 2, ≥3), cigarette smoking, Hepatitis C infection, body mass index, and number of injections in the past 30 days.
HIV status was adjusted for all participants.
CD4+ T-cell counts, HIV viral load, and cART use in past 6 months were adjusted for HIV-positive subgroup.